一种E2泛基素结合酶将二基素化H2B与H3K27M连接在一起,从而对基斯的功能起到作用
Alan L Jiao1,2, Erdem Sendinc2, Barry M Zee2
1Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
概括
研究人员在C. elegans中确定了H3K27M胆突变的遗传抑制剂,揭示了在扩散中线质瘤 (DMGs) 中恢复H3K27me3水平的机制. 这项工作为儿童大脑瘤提供了新的治疗点.
科学领域:
- 表观遗传学和癌症生物学
- 发育生物学和遗传学
背景情况:
- 在H3K27M基素突变驱动扩散的中线质瘤 (DMGs),其特点是H3K27三甲基化 (H3K27me3) 的全球损失.
- 这种H3K27M表型保留在像*Caenorhabditis elegans* (*C. elegans*) 这样的模型生物中,为遗传查提供了一个平台.
研究的目的:
- 为了确定*C. elegans*中H3K27M胆固醇突变的遗传抑制剂.
- 阐明在存在H3K27M突变的情况下恢复H3K27me3水平的基础分子机制.
主要方法:
- 在表达H3K27M胆固醇的*C. elegans*中进行了全基因组抑制选.
- 抑制器突变被映射到特定的基因中,并分析了它们对H3K27me3水平和蛋白质相互作用的影响.
- 在人类细胞中评估了已识别的抑制剂的功能性保存.
主要成果:
- 隔离了20种抑制剂,所有这些都部分恢复了H3K27me3水平.
- 19个抑制剂映射到组素H3.3基因中,导致氨基酸替代,预计会损害聚合物抑制复合物2 (PRC2) 相互作用.
- 鉴定出一种外原抑制剂,ubc-20 (一种E2泛素结合酶),它通过抑制H2B泛化来拯救H3K27me3.
结论:
- 在体内发现支持PRC2抑制的模型通过直接接触胆.
- 通过像UBC-20这样的酶调节H2B泛化,为H3K27M驱动的扩散中线质瘤提供了潜在的治疗策略.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Histone Modification
13.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.1K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
The Proteasome
815
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
815


